RCA with one BMS was performed. Although thrombus aspiration and balloon angioplasty of RPL were performed, noreflow occurred. The patient received intracoronary bolus of eptifibatide and during the next 18 hours eptifibatide infusion was continued. She was relived of chest pain and the ECG was normalized. After three days the patient once again had chest pain with inferoposterior STEMI. Coronary angiography showed a large thrombus in the implanted BMS with reduced TIMI flow but patent RPL. Because no thrombectomy catheter was available, only PTCA was done. A good angiographic result was achieved, but once again distal embolization and occlusion of RPL occurred. Eptifibatide infusion was continued during the next 30 hours and ST-segment resolution was obtained.
Discussion:
Patients with distal embolization and no-reflow have significantly higher rates of acute or subacute stent thrombosis. If mechanical thrombectomy is not available or fails, glycoprotein IIb/IIIa inhibitors are used with various efficacies. In our patient eptifibatide was useful in obtaining flow in the RPL, but nevertheless subacute stent thrombosis occurred. Therefore, more successful treatment options in these patients are needed.
Conclusion:
The presence of large coronary thrombus at the time of primary PCI still remains a challenge for the interventional cardiologist. It is associated with a greater frequency MACE and is a strong independent predictor of late mortality.
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